Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi-Aventis S.A. ADR (NQ: SNY ) 53.27 +0.39 (+0.74%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sanofi-Aventis S.A. ADR < Previous 1 2 ... 19 20 21 22 23 24 25 26 27 ... 31 32 Next > CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment June 07, 2022 Key Takeaways: CStone brought four products to market last year, and its losses have surged due to growing R&D and sales spending Appointment of chairman with close ties... Via Benzinga Acurx Pharmaceuticals Is Under The Radar, That’s Excellent News For Investors Wanting Exposure To Billion Dollar CDI Treatment Market ($ACXP) June 06, 2022 Via AB Newswire Exposures Product Safety The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More June 05, 2022 Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. Via Benzinga Regeneron Pharmaceuticals Dives On $1.1 Billion Deal To Rival Merck In Cancer June 02, 2022 Regeneron secured the global rights to Sanofi-partnered Libtayo. Via Investor's Business Daily FDA Accepts Regeneron, Sanofi's Filing For Review In Skin Disease May 31, 2022 The U.S. Via Benzinga Why Kymera Therapeutics Shares Are Falling Today May 03, 2022 Via Benzinga Dupixent, Consumer Healthcare Lifts Sanofi's Q1 Earnings, Backs FY22 Guidance April 28, 2022 Via Benzinga 3 Biotech Stocks to Buy Before They Boom June 01, 2022 It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations. Via InvestorPlace Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates May 31, 2022 May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... Via Benzinga Revolutionary Heart Therapy Offers Hope to Patients and Investors Alike May 31, 2022 Palm Beach, FL – May 31, 2022 – FinancialNewsMedia.com News Commentary – Diabetes is a chronic health condition that occurs when your body’s blood glucose, also called blood sugar, is too high. Blood... Via FinancialNewsMedia Sanofi Scores A Big Beat As Dupixent Snags The Spotlight, Again April 28, 2022 Dupixent sales rocketed higher in the quarter, driven by continued uptake in eczema treatment. Via Investor's Business Daily The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More May 22, 2022 Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support. Via Benzinga FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule May 20, 2022 The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals, Inc. Via Benzinga The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara May 20, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 7 Penny Stocks With 10x Potential This Year May 17, 2022 These penny stocks all have 10x potential or greater during the remainder of 2022. They are risky but relatively straightforward. Via InvestorPlace Sanofi To Pay €400K As Compensation For Epilepsy Drug-Related Side Effects May 16, 2022 A French court has ordered Sanofi SA (NASDAQ: SNY) to pay more than €400,000 in damages to a French family whose child had autism caused by its epilepsy drug Valproate. Via Benzinga Sanofi Says Sarclisa Shows 'Unprecedented Median Progression-Free Survival' In Multiple Myeloma Patients May 16, 2022 Via Benzinga Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices May 13, 2022 Arkansas has accused Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and three of the largest pharmacy benefit... Via Benzinga Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now May 13, 2022 The race is on in eczema treatment as the biggest name faces new rivals. Via Investor's Business Daily Psychedelic Medicine: The New Frontier In Healthcare, The Big Opportunity In Biopharma May 13, 2022 The story around psychedelic medicine continues to get bigger. Via Talk Markets Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY) May 11, 2022 Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space... Via Benzinga The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine May 11, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV May 11, 2022 Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV). Via Benzinga Heart Failure Treatment Offers Hope to Diabetics May 11, 2022 Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart... Via FinancialNewsMedia 7 Biotech Stocks With Key Catalysts for May May 11, 2022 The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. Via InvestorPlace Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review April 29, 2022 The Nasdaq hit its lowest level since 2020. Apple and Facebook led key earnings. Via Investor's Business Daily The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates April 28, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For April 28, 2022 April 28, 2022 Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion. Via Benzinga Microsoft Gives Glimpse Of Xbox Cloud Gaming Numbers April 27, 2022 Microsoft Corporation (NASDAQ: MSFT) CEO Satya Nadella said Tuesday that more than 10 million people have streamed games on its Xbox Cloud Gaming platform. What Happened: Nadella... Via Benzinga This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels April 26, 2022 This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a... Via Benzinga < Previous 1 2 ... 19 20 21 22 23 24 25 26 27 ... 31 32 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
